Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
Mayo Clin Proc
.
2020 Nov;95(11):2559-2561.
doi: 10.1016/j.mayocp.2020.09.010.
Epub 2020 Sep 14.
Authors
Aakash Garg
1
,
Amit Rout
2
,
Abhishek Sharma
3
,
Brittany Fiorello
4
,
John B Kostis
5
Affiliations
1
Mount Sinai Hospital, New York, New York; Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
2
Einstein Medical Center, Philadelphia, Pennsylvania.
3
Gundersen Health System, La Crosse, Wisconsin.
4
Mount Sinai Hospital, New York, New York.
5
Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
PMID:
33153642
PMCID:
PMC7489985
DOI:
10.1016/j.mayocp.2020.09.010
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus*
COVID-19*
Coronavirus Infections* / epidemiology
Humans
Pandemics
Renin-Angiotensin System